The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review

Abstract

Introduction In patients affected by epithelial ovarian cancer (EOC) complete cytoreduction (CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems have proved clinical benefice in different areas of healthcare. Objective To systematically assemble and analyze the available literature on the use of AI in patients affected by EOC to evaluate its applicability to predict CC compared to traditional statistics. Material and Methods Data search was carried out through PubMed, Scopus, Ovid MEDLINE, Cochrane Library, EMBASE, international congresses and clinical trials. The main search terms were: Artificial Intelligence AND surgery/cytoreduction AND ovarian cancer. Two authors independently performed the search by October 2022 and evaluated the eligibility criteria. Studies were included when data about Artificial Intelligence and methodological data were detailed. Results A total of 1899 cases were analyzed. Survival data were reported in 2 articles: 92% of 5-years overall survival (OS) and 73% of 2-years OS. The median area under the curve (AUC) resulted 0,62. The model accuracy for surgical resection reported in two articles reported was 77,7% and 65,8% respectively while the median AUC was 0,81. On average 8 variables were inserted in the algorithms. The most used parameters were age and Ca125. Discussion AI revealed greater accuracy compared against the logistic regression models data. Survival predictive accuracy and AUC were lower for advanced ovarian cancers. One study analyzed the importance of factors predicting CC in recurrent epithelial ovarian cancer and disease free interval, retroperitoneal recurrence, residual disease at primary surgery and stage represented the main influencing factors. Surgical Complexity Scores resulted to be more useful in the algorithms than pre-operating imaging. Conclusion AI showed better prognostic accuracy if compared to conventional algorithms. However further studies are needed to compare the impact of different AI methods and variables and to provide survival informations.

The Application of Artificial Intelligence to Cancer Research: A Comprehensive Guide

“…AI has shown promising results in studying different types of human cancers, 2 – 5 including but not limited to cervical cancer, 6 , 7 pancreatic cancer, 3 , 8 breast cancer, 9 , 10 colorectal cancer, 11 ovarian cancer, 12 laryngeal cancer, 13 brain cancer, 14 , 15 and lung cancer. 4 , 16 , 17 In a scoping review, the extent of the use of AI and ML protocols for cancer diagnosis in prospective settings was explored.…”

Empowering health care consumers & understanding patients' perspectives on AI integration in oncology and surgery: A perspective

“…In oncology, AI's application spans diagnosis, treatment planning, and predicting treatment outcomes, potentially increasing the accuracy and efficiency of cancer care. 2 Algorithms excel in processing complex medical images, pinpointing minute tumor changes that might elude the human eye. 3 In the surgical sphere, AI‐enhanced robotic systems provide surgeons with greater precision and control, leadingto minimallyinvasive procedures, shorter hospital stays, and quicker recovery times.…”

“…In oncology, AI's application spans diagnosis, treatment planning, and predicting treatment outcomes, potentially increasing the accuracy and efficiency of cancer care 2 . Algorithms excel in processing complex medical images, pinpointing minute tumor changes that might elude the human eye 3 .…”